EQS-News: Gerresheimer Achieves A- Score in CDP Rating

Gerresheimer Achieves A- Score in CDP Rating

• “Leadership” status in climate action
• Rating recognizes transparent management of CO₂ emissions
• Ambitious reduction target: 50% CO₂ emissions cut by 2030

Düsseldorf, July 15, 2025. Gerresheimer, an innovative system and solutions provider and global partner to the pharmaceutical, biotech, and cosmetics industries, has been awarded an A- rating by CDP for its transparent disclosure of climate-related goals, processes, and performance within its environmental management framework. This rating confers “Leadership” status and places Gerresheimer well above both the global average and the industry average, which each stand at a C rating. CDP is the world’s leading global nonprofit and independent organization for environmental data disclosure by companies, cities, states, and regions. This recognition further underscores Gerresheimer’s ongoing progress in implementing its sustainability strategy. Sustainability is an integral part of Gerresheimer’s corporate strategy, formula g.

"Our environmental management drives innovation and investments in cutting-edge technologies, ensuring the long-term sustainability of our company," said Dietmar Siemssen, CEO of Gerresheimer AG. "At the same time, by reducing our CO₂ emissions, we contribute to the climate protection goals of our customers."

Transparent Environmental Management

Since 2011, Gerresheimer has actively participated in CDP (formerly the Carbon Disclosure Project), one of the world’s largest initiatives for environmental impact disclosure and management. As part of this commitment, the company reports annually on its climate strategy and management approach. CO₂ emissions are collected, analyzed, and managed in a structured process across all production sites. Gerresheimer provides detailed annual updates on implemented measures and progress achieved. In the current CDP rating cycle, the company received top marks in subcategories including emission reduction initiatives, low-carbon products, management of dependencies, impacts, risks and opportunities, governance, as well as risk disclosure and data verification.

Ambitious CO₂ Reduction Target

Under its corporate strategy formula g, Gerresheimer aims to reduce its Scope 1 and Scope 2 emissions by 50% by 2030. Scope 1 emissions include all direct emissions generated by Gerresheimer’s operational activities, while Scope 2 emissions cover indirect emissions from energy supply. The company plans to lower its energy demand through state-of-the-art production technologies and to source 100% of its electricity from renewable energy by 2030. By the end of 2024, Gerresheimer had already achieved a 28% reduction in emissions compared to the base year 2019. The share of electricity from renewable sources had already reached 55% by the end of 2024.

Recognized Rating for CO₂ Emissions Disclosure and Management

CDP, founded in London in 2000, is a leading global nonprofit and independent organization that operates the world’s most comprehensive environmental data collection system. It annually evaluates organizations climate, water, and forest management performance on a scale from A to F, assessing their targets, processes, and outcomes. In 2024, 22,780 companies worldwide participated in the CDP rating, demonstrating transparency in their environmental management and commitment to building resilient business models.

About Gerresheimer 
Gerresheimer is an innovative systems and solutions provider and a global partner for the pharma, biotech and cosmetic industries. The Group offers a comprehensive portfolio of drug containment solutions including closures and accessories, as well as drug delivery systems, medical devices and solutions for the health industry. The product range includes digital solutions for therapy support, medication pumps, syringes, pens, auto-injectors and inhalers as well as vials, cartridges, ampoules, tablet containers, infusion, dropper and syrup bottles and more. Gerresheimer ensures the safe delivery and reliable administration of drugs to the patient. Gerresheimer supports its customers with comprehensive services along the value chain and in addressing the growing demand for enhanced sustainability. With over 40 production sites in 16 countries in Europe, America and Asia, Gerresheimer has a global presence and produces locally for regional markets. Together with Bormioli Pharma, the Group generated revenues of around EUR 2.4bn in 2024 and currently employs around 13,600 people. Gerresheimer AG is listed in the MDAX on the Frankfurt Stock Exchange (ISIN: DE000A0LD6E6).    
www.gerresheimer.com 

Contact Gerresheimer AG